# Trinity Biosystems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/trinity-biosystems

- Industry: Biotechnology
- Headquarters: Menlo Park, US
- Total disclosed funding: $23M
- Latest round: Series B (Jul 1, 2006)
- Investors on record: 4

## About

Founded in 2002, Trinity Biosystems, Inc. engages in the development and formulation of oral therapeutic proteins. It involves in developing vaccines in the areas of respiratory, digestive, and sexually transmitted diseases.

## Funding rounds

- Series B, Jul 1, 2006, $21M — Sanderling Ventures, Tenex Greenhouse Ventures, SR One, Amgen Ventures
- Series A, Sep 25, 2002, $1.5M — Sanderling Ventures, Tenex Greenhouse Ventures

## Investors

- Sanderling Ventures (https://capitalatlas.ai/funds/sanderling-ventures) — Series A, Series B
- Tenex Greenhouse Ventures (https://capitalatlas.ai/funds/tenex-greenhouse-ventures) — Series A, Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series B